BGMS · Bio Green Med Solution, Inc.
Substantial doubt about the company's ability to continue as a going concern.
“Our history of losses, our negative cash flows from operations, our liquidity resources currently on hand, and our dependence on the ability to obtain additional financing to fund our operations after the current resources are exhausted, about which there can be no certainty, have resulted in our assessment that there is substantial doubt about our ability to continue as a going concern for a period of at least twelve months from the issuance date of this Quarterly Report on Form 10-Q.”View the 10-Q filed Aug 14, 2026
4 customers — 55% of revenue (the December 31, 2025 financial year)
“In the December 31, 2025 financial year, our top four customers collectively accounted for 55% of the Company's total sales, with individual contributions of approximately 36%, 7%, 6%, and 6%, respectively.”
One customer — 36% of revenue (the December 31, 2025 financial year)
“In the December 31, 2025 financial year, our top four customers collectively accounted for 55% of the Company's total sales, with individual contributions of approximately 36%, 7%, 6%, and 6%, respectively.”
Key customers — 7% of revenue (the December 31, 2025 financial year)
“In the December 31, 2025 financial year, our top four customers collectively accounted for 55% of the Company's total sales, with individual contributions of approximately 36%, 7%, 6%, and 6%, respectively.”
Key customers — 6% of revenue (the December 31, 2025 financial year)
“In the December 31, 2025 financial year, our top four customers collectively accounted for 55% of the Company's total sales, with individual contributions of approximately 36%, 7%, 6%, and 6%, respectively.”
Key customers — 6% of revenue (the December 31, 2025 financial year)
“In the December 31, 2025 financial year, our top four customers collectively accounted for 55% of the Company's total sales, with individual contributions of approximately 36%, 7%, 6%, and 6%, respectively.”
Price & Indicators
Raw chart and full-history price indicators begin at the captured split on Jul 7, 2025; bars on opposite sides are not compared.
Up next
Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders SellIllustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Building Products & Equipment — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
BGMS
this stock
Bio Green Med Solution, Inc.
|
$5.73M | -41.6% | -100.0% | — | 0.9% |
|
TT
Trane Technologies plc
|
$98.78B | +14.2% | +5.6% | 34.0 | 1.3% |
|
JCI
Johnson Controls International plc
|
$85.17B | +15.4% | -4.2% | 25.2 | 1.6% |
|
CARR
CARRIER GLOBAL Corp
|
$48.83B | +10.2% | -3.3% | 38.4 | 1.8% |
|
CODGF
Compagnie De Saint Gobain
|
$45.24B | -11.9% | — | — | 0.2% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
Raw-price comparisons begin at the captured split on Jul 7, 2025; windows that need an earlier baseline remain unavailable.
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| BGMS | -0.6% | -1.7% | -9.0% | -2.8% | -41.6% |
| SPY | +0.5% | +1.2% | +13.3% | +2.7% | +12.5% |
| vs SPY | -1.0% | -2.9% | -22.2% | -5.5% | -54.0% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.